Euglycemic diabetic ketoacidosis following major vascular surgery is a new item on the differential for postoperative acidosis

New pharmacologic advances in the treatment of diabetes include SGLT-2 inhibitors, which have been demonstrated in randomized-controlled clinical trials to reduce overall and cardiac-specific mortality and slow progression of chronic kidney disease. Euglycemic diabetic ketoacidosis is a rare but lif...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez-Sanchez, Clara M., Wu, Bian X., Gotts, Jeffrey E., Chang, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591455/
https://www.ncbi.nlm.nih.gov/pubmed/34816071
http://dx.doi.org/10.1016/j.jvscit.2021.10.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591455/
https://www.ncbi.nlm.nih.gov/pubmed/34816071
http://dx.doi.org/10.1016/j.jvscit.2021.10.006

Ejemplares similares